About Xcell Biosciences

Xcell Biosciences is a San Francisco based life science start-up company that has developed an innovative high content primary cell culture platform for use in research, drug development, and precision medicine applications. The technology delivers simple, standardized culture of primary cell types from a variety of patient tissues and blood, including expansion of tumor cells and immune cells. This novel platform enables direct disease insights ex vivo, with use in drug development applications ranging from novel cancer biomarker discovery to cell-based immunotherapy lead optimization. This patient-centric company is developing the next generation of the platform as a liquid biopsy tools for cancer screening, diagnosis, and disease monitoring. Xcell Biosciences is an Illumina Accelerator company, a member of the Bayer CoLaborator, a BayBio FAST awardee, a OneStart Business Competition 2014 Finalist, QB3 nominated company in the “Most Intriguing Company” category for 2015, oral presenter in the liquid biopsy Minisymposia at the AACR 2015 national meeting, and is generating revenue from the launch of the Avatar system in 2016.

Learn more at www.xcellbio.com